Holbrook E. Kohrt

18.3k citations
147 papers · 7.8k · 3 hit papers · h-index 45

Impact in

  • Immunology top 0.2%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immune cells in cancer
    • Phagocytosis and Immune Regulation
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Immune Cell Function and Interaction 55
    • Immunotherapy and Immune Responses 50
    • T-cell and B-cell Immunology 21
    • CAR-T cell therapy research 52
    • Cancer Immunotherapy and Biomarkers 33

Holbrook E. Kohrt

145 papers receiving 7.7k citations

Holbrook E. Kohrt's Hit Papers

Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody 2016 · 281 citations
2810+5+10Years since publication250500750

Peers

Holbrook E. Kohrt
Comparison fields: 5 of 130
  • Immunology 4.7k
  • Oncology 4.3k
  • Hematology 768
  • Genetics 543
  • Pathology and Forensic Medicine 865
Replace Christoph Huber with:
Christoph Huber Germany
Philipp Beckhove Germany
Inge Marie Svane Denmark
Helmut R. Salih Germany
Gunnar Kvalheim Norway
Frederic I. Preffer United States
Shinsuke Iida Japan
Ivan Borrello United States
John Wagstaff United Kingdom
Marcus O. Butler Canada
Holbrook E. Kohrt relative to Christoph Huber Germany Christoph Huber's profile →
Citations per field
00.5×1.5×2.2×
Christoph Huber · 1×
Citations per year

Countries citing papers authored by Holbrook E. Kohrt

Since Specialization
Citations

This map shows the geographic impact of Holbrook E. Kohrt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holbrook E. Kohrt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holbrook E. Kohrt more than expected).

Fields of papers citing papers by Holbrook E. Kohrt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holbrook E. Kohrt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holbrook E. Kohrt. The network helps show where Holbrook E. Kohrt may publish in the future.

Co-authors

The 25 scholars most cited alongside Holbrook E. Kohrt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Holbrook E. Kohrt Line = papers co-authored together Holbrook E. Kohrt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Hit paper breakdown →
2010845
2 2015358
3
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
Hit paper breakdown →
2015352
4
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
Hit paper breakdown →
2016281
5 2013279
6 2013251
7 2013229
8 2008196
9 2014181
10 2016179
11 2005166
12 2015155
13 2016150
14 2015147
15 2011146
16 2017143
17 2012137
18 2016133
19 2013133
20 2012132

About Holbrook E. Kohrt

Holbrook E. Kohrt is a scholar working on Immunology, Oncology, Hematology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 147 papers that have together received 7.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (55 papers), CAR-T cell therapy research (52 papers), Immunotherapy and Immune Responses (50 papers), Cancer Immunotherapy and Biomarkers (33 papers), Lymphoma Diagnosis and Treatment (26 papers), T-cell and B-cell Immunology (21 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Hematopoietic Stem Cell Transplantation (17 papers). The work is most often cited by research in Immunology (4.7k citations), Oncology (4.3k citations), Hematology (768 citations), Genetics (543 citations) and Pathology and Forensic Medicine (865 citations). Holbrook E. Kohrt has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Ronald Levy, Aurélien Marabelle, Cariad Chester, Roch Houot, Idit Sagiv-Barfi, Debra K. Czerwinski, Ash A. Alizadeh, Joshua Brody, June H. Myklebust and Bruno C. Medeiros. Their work appears in journals such as Blood, Journal for ImmunoTherapy of Cancer, Clinical Cancer Research, OncoImmunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact